From Nasdaq
February 25, 2025 4:42:00 PM:

The Zacks Research Daily presents new reports on 16 major stocks, including Charles Schwab Corp. (SCHW), Gilead Sciences, Inc. (GILD), and Medtronic plc (MDT). Micro-cap stocks Cooper-Standard Holdings Inc. (CPS) and Rave Restaurant Group, Inc. (RAVE) are also featured. Charles Schwab focuses on net interest margin expansion and client asset growth, projecting a 2.13% NIM in 2024.

Gilead Sciences reported strong Q4 results and projects a positive outlook for 2025. Its HIV therapy, Biktarvy, continues to drive growth, with potential approval for lenacapavir to prevent HIV. Sales estimates for Biktarvy indicate a CAGR of around 4.5% over the next three years. Gilead aims to enhance its franchises in oncology and virology.

Medtronic strategically expands its global presence to meet demand for advanced medical devices. The company’s Cardiovascular segment gains market share, driven by product launches in CRM and Structural Heart. Medtronic’s Pacing business is experiencing strong growth with Micra leadless pacemaker. The company maintains a strong liquidity position to meet near-term debt obligations.

Cooper-Standard Holdings Inc., a micro-cap company, expanded margins despite lower revenue. It aims for double-digit margins by Q4 2025, with cost optimizations delivering over $100 million in savings. However, high debt and rising interest costs pose risks, with challenges from weak global auto production and pricing pressure from automakers.

Rave Restaurant Group, another micro-cap company, saw 19 consecutive quarters of positive earnings. In Q2 fiscal 2025, net income rose to $0.6 million, with adjusted EBITDA up to $0.8 million. Yet, challenges remain with Pie Five’s sales decline and ongoing challenges. The company’s reliance on supplier incentives and digital lag pose risks, while growth strategies execution is key.

Read more at Nasdaq: Top Stock Reports for Charles Schwab, Gilead Sciences & Medtronic